Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000227889 | SCV000284678 | pathogenic | Tuberous sclerosis 1 | 2015-12-25 | criteria provided, single submitter | clinical testing | This sequence change deletes 2 nucleotides from exon 15 of the TSC1 mRNA (c.1530_1531delCA), causing a frameshift at codon 510. This creates a premature translational stop signal (p.Asp510Glufs*24) and is expected to result in an absent or disrupted protein product. Truncating variants in TSC1 are known to be pathogenic (PMID: 10533067, 10227394). This particular truncation has been reported in the literature in an individual affected with tuberous sclerosis complex (TSC) (PMID: 9242607). This variant is also known as 1750delCA in the literature and as c.1529_1530delAC in ClinVar (Variation ID:48798). For these reasons, this variant has been classified as Pathogenic. |
Tuberous sclerosis database |
RCV000042045 | SCV000065828 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |